Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carotid plaque regression on oestrogen replacement: a pilot study

A Akkad1, T Hartshorne, P R Bell

  • 1Menopause Research Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Leicester, U.K.

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|April 1, 1996
PubMed
Summary

Oestrogen replacement therapy significantly reduced carotid plaque size in postmenopausal women. This hormone therapy demonstrated a notable regression in atheromatous plaques, suggesting a potential therapeutic benefit for cardiovascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

46th Medical Maghrebian Congress. November 9-10, 2018. Tunis.

La Tunisie medicale·2019
Same author

Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency.

Climacteric : the journal of the International Menopause Society·2018
Same author

Post NICE Guidelines: could precision prescribing of estrogen be achieved?

Climacteric : the journal of the International Menopause Society·2016
Same author

Lack of association between ESR1 gene polymorphisms and premature ovarian failure in Serbian women.

Climacteric : the journal of the International Menopause Society·2013
Same author

Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.

Climacteric : the journal of the International Menopause Society·2010

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Vascular Biology

Background:

  • Atheromatous carotid plaques are a significant risk factor for stroke.
  • Estrogen's role in cardiovascular health is complex and debated, particularly in postmenopausal women.
  • Understanding the impact of hormone replacement therapy on established atherosclerotic lesions is crucial.

Purpose of the Study:

  • To evaluate the effect of unopposed estrogen on the regression of atheromatous carotid plaques.
  • To assess changes in carotid plaque dimensions and intimal thickness following estrogen treatment.

Main Methods:

  • A cohort of 17 postmenopausal women with diagnosed carotid artery disease was enrolled.
  • Duplex ultrasound was used to measure carotid intimal thickness, plaque length, and thickness at baseline, 3 months, and 6 months.

Related Experiment Videos

  • Twenty-two carotid plaques were monitored throughout the 6-month treatment period.

    • Main Results:

    • Carotid plaque length significantly decreased by 8.14% at 3 months (p=0.001) and 28% at 6 months (p=0.001).
    • Plaque thickness showed a significant reduction of 18% after 6 months of treatment (p=0.004).
    • No statistically significant changes were observed in carotid intimal thickness.

    Conclusions:

    • Estrogen replacement therapy is associated with significant regression of atheromatous carotid plaques.
    • These findings suggest a potential benefit of estrogen therapy in managing carotid atherosclerosis.
    • Further research is warranted to explore the mechanisms and long-term implications of estrogen-induced plaque regression.